| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| R&D Expense | $60K | — | -2.5% |
| SG&A Expense | $4.6M | — | +1983.1% |
| Operating Income | -$4.7M | — | -1507.2% |
| Pre-tax Income | -$4.8M | — | -1265.4% |
| Net Income | -$4.8M | — | -1265.4% |
| EPS (Basic) | -$0.39 | — | — |
| EPS (Diluted) | -$0.39 | — |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Current Assets | $8.8M | +4.9% | — |
| Total Assets | $18.0M | -8.4% | — |
| Current Liabilities | $3.6M | -36.0% | -12.9% |
| Long-term Debt | $107K | -80.1% | -72.0% |
| Total Liabilities | $3.6M | -36.9% | -13.4% |
| Stockholders' Equity | $14.4M |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$1.9M | — | -723.3% |
| Capital Expenditures | $2K | — | — |
| Investing Cash Flow | -$2K | — | — |
| Financing Cash Flow | $2.5M | — | +1071.4% |
| Free Cash Flow | -$1.9M | — | — |
| — |
| +3.3% |
| +449.6% |